Purchase Order 75N92022P00203
Award Date 7/30/22
Potential Completion Date 12/30/22
Potential Value $303K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $265,954.69 firm fixed price purchase order to Becton, Dickinson and Company for a FACS Melody Cell Sorter. BD Biosciences, a division of BD, will provide the cell sorting instrument as the prime contractor. The place of performance is in San Jose, California and the period of performance completion date is January 29, 2021. No set-aside designation was used for this...
- Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $29,795.40 on January 23, 2019, for a maintenance agreement with an ultimate completion date of January 31, 2020. Work is performed at Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied. The maintenance agreement supports BD flow cytometry instrumentation operated by the Institute, consistent with BD Biosciences' established supplier...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $834,695.07 purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the delivery of a FACSDISCOVER S8 CELL SORTER. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide the cell sorting instrument from its parent company Becton, Dickinson And Company's BD Biosciences division....
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $64,908 firm fixed price purchase order to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for maintenance services for the CantoiI flow cytometer analyzer. The prime contractor, Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division, will provide maintenance services for the flow cytometer located in Bethesda, Maryland...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at one hundred sixty-five thousand five hundred seventeen dollars and thirteen cents ($165,517.13) to Becton, Dickinson and Company for a BD FACSymphony A1 cell analyzer. Becton, Dickinson and Company will deliver the requested cell analyzer as the prime contractor. No set-aside designation was used for this award. Performance will occur at Sparks Glencoe, Maryland by...
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Co on September 11, 2020, for a fluorescence activated cell sorting system valued at $831,063.75, with performance completing December 10, 2020. Performance is at Bethesda, Maryland. The requirement specifies a high-dimensional cell sorting system capable of high-parameter single cell analysis for human research, including five lasers able to analyze up to 30 parameters and colors, with accompanying...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a service agreement to provide a FACSMelody cell sorter. The contract has a ceiling value of $16,092 and a completion date of December 19, 2022. This award is not associated with a set-aside program. BD is a global medical technology company that provides specialized instruments,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $302,669.97 firm fixed price purchase order contract to Becton, Dickinson And Company BD Biosciences, Systems And Reagents Division for the purchase of a BD Biosciences FACS Melody Flow Sorter. The place of performance is Bethesda, Maryland and the period of performance is from July 30, 2022 through December 30, 2022. No applicable subcontractors were identified.
Generated 11/27/23, 9:59 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($37) | 11/14/23 | |
| Not listed | Not listed | $302.7k | 7/29/22 |